Oncotherapeutics

NCT03104270

Phase 2Terminated201713 people7 Apr 2017clinicaltrials.gov

NCT02294357

Phase 2Terminated201445 people19 Nov 2014clinicaltrials.gov

NCT02206425

Phase 1/2Completed201445 people1 Aug 2014clinicaltrials.gov

NCT02188368

Phase 2Terminated201445 people11 Jul 2014clinicaltrials.gov

NCT01792102

Phase 1/2Status unknown201338 people15 Feb 2013clinicaltrials.gov

NCT01541332

Phase 1/2Status unknown201270 people29 Feb 2012clinicaltrials.gov

NCT01160484

Phase 2Completed200940 people12 Jul 2010clinicaltrials.gov

NCT00742404

Phase 2Status unknown200835 people27 Aug 2008clinicaltrials.gov

NCT00317811

Phase 2Completed200535 people25 Apr 2006clinicaltrials.gov

NCT00085345

Phase 2Withdrawn0 people11 Jun 2004clinicaltrials.gov